COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator
Purpose: Coatomer protein complex subunit beta 2 (COPB2) is a crucial component of the coatomer protein complex I, responsible for vesicle transport. Previous studies have indicated that COPB2 is highly expressed in malignant tumors and is involved in cell proliferation and apoptosis. However, the r...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Journal of Bone Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137425000430 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849419374001127424 |
|---|---|
| author | Yunpeng Cui Xuedong Shi Qiwei Wang Wence Wu Yuanxing Pan Bing Wang Mingxing Lei |
| author_facet | Yunpeng Cui Xuedong Shi Qiwei Wang Wence Wu Yuanxing Pan Bing Wang Mingxing Lei |
| author_sort | Yunpeng Cui |
| collection | DOAJ |
| description | Purpose: Coatomer protein complex subunit beta 2 (COPB2) is a crucial component of the coatomer protein complex I, responsible for vesicle transport. Previous studies have indicated that COPB2 is highly expressed in malignant tumors and is involved in cell proliferation and apoptosis. However, the role of COPB2 in osteosarcoma and its underlying mechanisms remain unclear. This study aimed to investigate the impact of COPB2 on proliferation, apoptosis, and colony formation in human osteosarcoma cells, as well as to explore potential mechanisms. Methods: Kaplan-Meier survival analysis was conducted to assess the association between COPB2 expression and the prognosis of osteosarcoma patients using data extracted from the Cancer Genome Atlas (TCGA) database. Additionally, COPB2 expression was examined in osteosarcoma tissue samples and four osteosarcoma cell lines using immunohistochemistry and quantitative real-time PCR (qRT-PCR). COPB2 expression was downregulated using siRNA in U2OS and SAOS-2 human osteosarcoma cells. Cell proliferation and colony formation were assessed using Cellomics/Celigo and Giemsa staining, respectively. Flow cytometry was used to evaluate cell cycle distribution and apoptosis. Tumor growth was evaluated in vivo model. Furthermore, the regulation mechanism of COPB2 on osteosarcoma cells was investigated using the Human Phospho-Kinase Array Kit. Results: Patients with high COPB2 expression exhibited shorter overall survival and disease-free survival compared to those with low COPB2 expression. COPB2 was found to be highly expressed in osteosarcoma tissue samples and cell lines. Silencing of COPB2 significantly inhibited cell proliferation and colony formation. Additionally, COPB2 silencing altered the cell cycle distribution, leading to cell cycle arrest in the G2 phase, and promoted cell apoptosis in osteosarcoma cells. Further investigations revealed that COPB2 silencing inhibited tumor growth and lung metastases of osteosarcoma cells in vivo, and its effects on cell proliferation and apoptosis may be mediated through the regulation of kinase phosphorylation levels. Conclusions: COPB2 expression is increased in osteosarcoma cells and plays a crucial role in cell growth regulation. Silencing of COPB2 inhibits cell proliferation, colony formation, and promotes cell apoptosis. Furthermore, COPB2 silencing inhibits tumor growth in vivo, suggesting its potential as an important therapeutic target in treating osteosarcoma. |
| format | Article |
| id | doaj-art-de441f28ee27491eb97adc62f3e50148 |
| institution | Kabale University |
| issn | 2212-1374 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Bone Oncology |
| spelling | doaj-art-de441f28ee27491eb97adc62f3e501482025-08-20T03:32:07ZengElsevierJournal of Bone Oncology2212-13742025-08-015310070210.1016/j.jbo.2025.100702COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicatorYunpeng Cui0Xuedong Shi1Qiwei Wang2Wence Wu3Yuanxing Pan4Bing Wang5Mingxing Lei6Department of Orthopedic Surgery, Peking University First Hospital, Beijing, PR ChinaDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing, PR China; Corresponding author at: Department of Orthopedic Surgery, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, PR China.Department of Orthopedic Surgery, Peking University First Hospital, Beijing, PR ChinaDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing, PR ChinaDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing, PR ChinaDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing, PR ChinaDepartment of Orthopedic Surgery, Chinese PLA General Hospital, Beijing, PR China; Department of Orthopedic Surgery, Hainan Hospital of Chinese PLA General Hospital, Sanya, PR China; Department of Orthopedic Surgery, National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Beijing, PR China; Corresponding author at: Department of Orthopaedic Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, PR China.Purpose: Coatomer protein complex subunit beta 2 (COPB2) is a crucial component of the coatomer protein complex I, responsible for vesicle transport. Previous studies have indicated that COPB2 is highly expressed in malignant tumors and is involved in cell proliferation and apoptosis. However, the role of COPB2 in osteosarcoma and its underlying mechanisms remain unclear. This study aimed to investigate the impact of COPB2 on proliferation, apoptosis, and colony formation in human osteosarcoma cells, as well as to explore potential mechanisms. Methods: Kaplan-Meier survival analysis was conducted to assess the association between COPB2 expression and the prognosis of osteosarcoma patients using data extracted from the Cancer Genome Atlas (TCGA) database. Additionally, COPB2 expression was examined in osteosarcoma tissue samples and four osteosarcoma cell lines using immunohistochemistry and quantitative real-time PCR (qRT-PCR). COPB2 expression was downregulated using siRNA in U2OS and SAOS-2 human osteosarcoma cells. Cell proliferation and colony formation were assessed using Cellomics/Celigo and Giemsa staining, respectively. Flow cytometry was used to evaluate cell cycle distribution and apoptosis. Tumor growth was evaluated in vivo model. Furthermore, the regulation mechanism of COPB2 on osteosarcoma cells was investigated using the Human Phospho-Kinase Array Kit. Results: Patients with high COPB2 expression exhibited shorter overall survival and disease-free survival compared to those with low COPB2 expression. COPB2 was found to be highly expressed in osteosarcoma tissue samples and cell lines. Silencing of COPB2 significantly inhibited cell proliferation and colony formation. Additionally, COPB2 silencing altered the cell cycle distribution, leading to cell cycle arrest in the G2 phase, and promoted cell apoptosis in osteosarcoma cells. Further investigations revealed that COPB2 silencing inhibited tumor growth and lung metastases of osteosarcoma cells in vivo, and its effects on cell proliferation and apoptosis may be mediated through the regulation of kinase phosphorylation levels. Conclusions: COPB2 expression is increased in osteosarcoma cells and plays a crucial role in cell growth regulation. Silencing of COPB2 inhibits cell proliferation, colony formation, and promotes cell apoptosis. Furthermore, COPB2 silencing inhibits tumor growth in vivo, suggesting its potential as an important therapeutic target in treating osteosarcoma.http://www.sciencedirect.com/science/article/pii/S2212137425000430COPB2OsteosarcomaCell growthColony formationMechanisms |
| spellingShingle | Yunpeng Cui Xuedong Shi Qiwei Wang Wence Wu Yuanxing Pan Bing Wang Mingxing Lei COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator Journal of Bone Oncology COPB2 Osteosarcoma Cell growth Colony formation Mechanisms |
| title | COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator |
| title_full | COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator |
| title_fullStr | COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator |
| title_full_unstemmed | COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator |
| title_short | COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator |
| title_sort | copb2 as a key regulator of cell growth in human osteosarcoma cells potential therapeutic target and prognostic indicator |
| topic | COPB2 Osteosarcoma Cell growth Colony formation Mechanisms |
| url | http://www.sciencedirect.com/science/article/pii/S2212137425000430 |
| work_keys_str_mv | AT yunpengcui copb2asakeyregulatorofcellgrowthinhumanosteosarcomacellspotentialtherapeutictargetandprognosticindicator AT xuedongshi copb2asakeyregulatorofcellgrowthinhumanosteosarcomacellspotentialtherapeutictargetandprognosticindicator AT qiweiwang copb2asakeyregulatorofcellgrowthinhumanosteosarcomacellspotentialtherapeutictargetandprognosticindicator AT wencewu copb2asakeyregulatorofcellgrowthinhumanosteosarcomacellspotentialtherapeutictargetandprognosticindicator AT yuanxingpan copb2asakeyregulatorofcellgrowthinhumanosteosarcomacellspotentialtherapeutictargetandprognosticindicator AT bingwang copb2asakeyregulatorofcellgrowthinhumanosteosarcomacellspotentialtherapeutictargetandprognosticindicator AT mingxinglei copb2asakeyregulatorofcellgrowthinhumanosteosarcomacellspotentialtherapeutictargetandprognosticindicator |